Oncolix Inc Perú 2021


SNNLive spoke with Michael Redman, President and CEO of Oncolix, Inc., (OTCQB: ONCX) at the LD Micro Invitational 2018 in Bel Air, CA. For more information …

The U.S. FDA has cleared our Investigational New Drug (IND) application to commence human testing of Prolanta™ for the treatment of ovarian cancer, which is …


Leave a comment

Your email address will not be published. Required fields are marked *